Capital Group Investment Management Pte. Ltd. Alnylam Pharmaceuticals, Inc. Transaction History
Capital Group Investment Management Pte. Ltd.
- $444 Million
- Q2 2024
A detailed history of Capital Group Investment Management Pte. Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital Group Investment Management Pte. Ltd. holds 19,570 shares of ALNY stock, worth $5.28 Million. This represents 1.07% of its overall portfolio holdings.
Number of Shares
19,570
Previous 16,173
21.0%
Holding current value
$5.28 Million
Previous $2.42 Million
96.73%
% of portfolio
1.07%
Previous 0.45%
Shares
6 transactions
Others Institutions Holding ALNY
# of Institutions
639Shares Held
109MCall Options Held
2.33MPut Options Held
2.15M-
Capital World Investors Los Angeles, CA15MShares$4.04 Billion0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.5MShares$3.38 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.58 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA6.21MShares$1.68 Billion0.28% of portfolio
-
Baillie Gifford & CO6.03MShares$1.63 Billion1.16% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.2B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...